Mark H Zangmeister Center - SCRI - PPDS is a clinical research site located in Columbus, Ohio, United States 43219.
Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.
Mark H Zangmeister Center - SCRI - PPDS has participated in 1 clinical trials with 1 currently active.
Therapeutic areas: Pancreatic Cancer Metastatic, Pancreatic Ductal Adenocarcinoma, Pancreatic Cancer Stage IV.
Sponsors: Panbela Therapeutics, Inc..
Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Mark H Zangmeister Center - SCRI - PPDS has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Mark H Zangmeister Center - SCRI - PPDS has 1 clinical trials on record, with 1 currently active. Their work covers Pancreatic Cancer Metastatic, Pancreatic Ductal Adenocarcinoma, Pancreatic Cancer Stage IV.
Mark H Zangmeister Center - SCRI - PPDS has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.